DRI Healthcare Trust (DHT.UN) Stock Price, News & Analysis

Company Overview

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$12.84 to C$13.20
• 50-Day Range: C$11.45 to C$14.73
• 52-Week Range: C$10.39 to C$17.43
• Volume: 125,816 shs
• Average Volume: 43,838 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 3.53%
• Price Target: C$18.00
• Consensus Rating: Moderate Buy

DRI Healthcare Trust Stock Analysis - MarketRank™

DRI Healthcare Trust scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

DRI Healthcare Trust has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

DRI Healthcare Trust has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of DRI Healthcare Trust is -260.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of DRI Healthcare Trust is -260.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

DRI Healthcare Trust has a P/B Ratio of 1.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for DHT.UN.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

DRI Healthcare Trust pays a meaningful dividend of 3.26%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

DRI Healthcare Trust does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for DHT.UN.

News and Social Media

• Score: 0.8 / 5
• News Sentiment: -0.50

News Sentiment

DRI Healthcare Trust has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for DRI Healthcare Trust this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, DRI Healthcare Trust insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.14% of the stock of DRI Healthcare Trust is held by insiders.

Percentage Held by Institutions

48.42% of the stock of DRI Healthcare Trust is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DHT.UN Stock Analysis - Frequently Asked Questions

How have DHT.UN shares performed this year?

DRI Healthcare Trust's stock was trading at C$12.48 at the start of the year. Since then, DHT.UN stock has increased by 4.4% and is now trading at C$13.03.
View the best growth stocks for 2024 here.

How do I buy shares of DRI Healthcare Trust?

Shares of DHT.UN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Company Calendar

• Ex-Dividend for 10/18 Dividend: 9/27/2024
• Dividend Payable: 10/18/2024
• Today: 11/15/2024

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:DHT.UN
• CUSIP: N/A
• CIK: N/A
• Web: www.dricapital.com
• Phone: 416-863-1865
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$18.00
• High Stock Price Target: C$22.00
• Low Stock Price Target: C$14.00
• Potential Upside/Downside: +38.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.86
• Research Coverage: 7 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 20.50
• P/E Growth: N/A
• Net Income: C$9.73 million
• Net Margins: 5.02%
• Pretax Margin: N/A
• Return on Equity: 2.06%
• Return on Assets: 4.22%

Debt

• Debt-to-Equity Ratio: 63.20
• Current Ratio: 1.36
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$193.66 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$9.32 per share
• Price / Book: 1.40

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: 0.60